Status:
COMPLETED
Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use
Lead Sponsor:
Duke University
Collaborating Sponsors:
Medtronic
Conditions:
Sudden Cardiac Arrest
Eligibility:
All Genders
19+ years
Brief Summary
The investigators will examine whether an educational video increases patient knowledge about heart failure and the risk of sudden cardiac arrest and leads to greater satisfaction with information pro...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Class I primary prevention indications for an implantable cardioverter defibrillator (ICD). These include:
- Patients with ejection fraction \<35% due to prior myocardial infarction (MI) who are at least 40 days post-MI and with New York Heart Association (NYHA) functional class II or III;OR
- Patients with nonischemic dilated cardiomyopathy (DCM) who have an LVEF \< 35% and who meet criteria for NYHA functional class II or III; OR
- Patients with left ventricular dysfunction due to prior MI who are at least 40 days post-MI, have an left ventricular ejection fraction (LVEF) \<30% and are in NYHA functional class I-III; OR
- Patients with nonsustained ventricular tachycardia (VT) due to prior MI, LVEF \<40%, and with inducible ventricular fibrillation (VF) or sustained VT at electrophysiological study; AND
- Self identified race as black/African American or white/Caucasian
Exclusion
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00918125
Start Date
November 1 2010
End Date
April 1 2012
Last Update
October 19 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Alamance Regional Medical Center
Burlington, North Carolina, United States, 27215
2
Duke University Medical Center
Durham, North Carolina, United States, 27715